{"symbol": "IMMP", "companyName": "Immutep Limited", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.primabiomed.com.au", "description": "Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.", "CEO": "Marc Voigt", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}